Wu S - Search Results

1

Sub-region based radiomics analysis for survival prediction in oesophageal tumours treated by definitive concurrent chemoradiotherapy.

Xie C, Yang P, Zhang X, Xu L, Wang X, Li X, Zhang L, Xie R, Yang L, Jing Z, Zhang H, Ding L, Kuang Y, Niu T, Wu S. Xie C, et al. Among authors: wu s. EBioMedicine. 2019 Jun;44:289-297. doi: 10.1016/j.ebiom.2019.05.023. Epub 2019 May 23. EBioMedicine. 2019. PMID: 31129097 Free PMC article.

2

[Efficacy of combined paclitaxel and oxaliplatin therapy in patients with pretreated advanced non-small cell lung cancer].

Xie CY, Wu SX, Zhang P. Xie CY, et al. Ai Zheng. 2004 Aug;23(8):947-50. Ai Zheng. 2004. PMID: 15301721 Chinese.

3

Optimal steel thickness combined with computed radiography for portal imaging of nasopharyngeal cancer patients.

Wu S, Jin X, Xie C, Cao G. Wu S, et al. Med Phys. 2005 Oct;32(10):3112-6. doi: 10.1118/1.2042267. Med Phys. 2005. PMID: 16279063 Clinical Trial.

4

[The relationship between the parotid glands function and the dose-volume effect in nasopharyngeal carcinoma patients with intensity-modulated radiation therapy].

Sun XN, Chen AZ, Xie CY, Jin XC, Wu SX, Zhang P, Li HB. Sun XN, et al. Zhonghua Yi Xue Za Zhi. 2006 Aug 29;86(32):2289-92. Zhonghua Yi Xue Za Zhi. 2006. PMID: 17064579 Chinese.

5

[Simultaneous modulated accelerated radiation therapy in the treatment of nasopharyngeal cancer].

Xie CY, Wu SX, Jin XC, Yu JY, Wang JH, Li WF, Zhang P. Xie CY, et al. Zhonghua Yi Xue Za Zhi. 2007 Sep 11;87(34):2412-5. Zhonghua Yi Xue Za Zhi. 2007. PMID: 18036320 Chinese.

6

[Concurrent chemoradiation with paclitaxel and platinum for locally advanced esophageal cancer].

Zhang P, Xie CY, Wu SX. Zhang P, et al. Zhonghua Zhong Liu Za Zhi. 2007 Oct;29(10):773-7. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 18396692 Chinese.

7

[Concurrent standard dose of cisplatin, paclitaxel, and radiotherapy followed by surgery in treatment of thoracic esophageal carcinoma].

Jiang YY, Wu SX, Zhang P, Xie CY, Wang J, Sun CC. Jiang YY, et al. Zhonghua Yi Xue Za Zhi. 2008 Aug 12;88(31):2171-4. Zhonghua Yi Xue Za Zhi. 2008. PMID: 19080664 Chinese.

8

Reverse resistance to radiation in KYSE-150R esophageal carcinoma cell after epidermal growth factor receptor signal pathway inhibition by cetuximab.

Jing Z, Gong L, Xie CY, Zhang L, Su HF, Deng X, Wu SX. Jing Z, et al. Radiother Oncol. 2009 Dec;93(3):468-73. doi: 10.1016/j.radonc.2009.08.008. Epub 2009 Sep 8. Radiother Oncol. 2009. PMID: 19744737

9

Phase II study of concurrent chemoradiation in combination with erlotinib for locally advanced esophageal carcinoma.

Li G, Hu W, Wang J, Deng X, Zhang P, Zhang X, Xie C, Wu S. Li G, et al. Among authors: wu s. Int J Radiat Oncol Biol Phys. 2010 Dec 1;78(5):1407-12. doi: 10.1016/j.ijrobp.2009.10.012. Epub 2010 Mar 28. Int J Radiat Oncol Biol Phys. 2010. PMID: 20350790 Clinical Trial.

10

[The effect on life quality of nasopharyngeal cancer patients through xerostomia decrease after intensity-modulated radiotherapy].

Xie CY, Su HF, Li WF, Zhang XB, Zhang P, Wen HL, Wu SX. Xie CY, et al. Zhonghua Yi Xue Za Zhi. 2010 May 18;90(19):1313-6. Zhonghua Yi Xue Za Zhi. 2010. PMID: 20646578 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40,450 results

Search Page

Filters